IDiyas

For the Inventor, By the Inventor

Doylestown, PA, United States of America

Andrew John Cooke

USPTO Granted Patents = 15 


Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Newhouse, GB (2012 - 2013)
  • Doylestown, PA (US) (2015 - 2018)
  • West Point, PA (US) (2015 - 2018)

Company Filing History:

goldMedal12 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal2 out of 17 
 
Msd Oss B.v.
 patents
bronzeMedal1 out of 55 
 
Merck Sharp + Dohme B.v.
 patents
4. 1 out of 101 
 
Pharmacopeia Inc.
 patents
where one patent can have more than one assignee

Years Active: 2012-2018

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 9914736 - TrKA kinase inhibitors, compositions and methods thereof (2018-03-13),
2. 9896447 - TrkA kinase inhibitors, compositions and methods thereof (2018-02-20),
3. 9862716 - TRKA kinase inhibitors, compositions and methods thereof (2018-01-09),
4. 9844553 - Pyrazolopyridyl compounds as aldosterone synthase inhibitors (2017-12-19),
5. 9815846 - TrkA kinase inhibitors, compositions and methods thereof (2017-11-14),
6. 9718782 - TrkA kinase inhibitors, compositions and methods thereof (2017-08-01),
7. 9567333 - Triazolopyridyl compounds as aldosterone synthase inhibitors (2017-02-14),
8. 9550786 - 4-fluoropiperidine orexin receptor antagonists (2017-01-24),
9. 9522141 - Indazole compounds as aldosterone synthase inhibitors (2016-12-20),
10. 9518055 - Imidazopyridyl compounds as aldosterone synthase inhibitors (2016-12-13),
11. 9351973 - Pyrazolopyridyl compounds as aldosterone synthase inhibitors (2016-05-31),
12. 9193724 - Triazolopyridyl compounds as aldosterone synthase inhibitors (2015-11-24),
13. 9108939 - (1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis (2015-08-18),
14. 8357679 - Hexafluoroisopropanol derivatives (2013-01-22),
15. 8314091 - N-benzyl,N'-arylcarbonylpiperazine derivatives (2012-11-20),

Title: Innovations and Contributions of Andrew John Cooke

Introduction

Andrew John Cooke is a notable inventor based in Doylestown, PA (US), recognized for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, Cooke has made substantial advancements in the development of therapeutic compounds.

Latest Patents

Among his latest patents, Cooke has developed TrKA kinase inhibitors, which are directed towards substituted five-membered heteroaryl benzamide compounds. These compounds are designed to inhibit tropomyosin-related kinase (Trk) family protein kinases, making them useful in treating various conditions such as pain, inflammation, cancer, and more. Another patent involves benzyl urea compounds that also target Trk family protein kinases, further expanding the potential applications in treating diseases associated with nerve growth factor receptor abnormalities.

Career Highlights

Throughout his career, Cooke has worked with prominent companies, including Merck Sharp & Dohme Corporation and MSD Oss B.V. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Cooke has collaborated with notable colleagues, including Emma Louise Carswell and Craig A. Stump, enhancing the innovation process through teamwork and shared expertise.

Conclusion

Andrew John Cooke's innovative work in the field of biotechnology, particularly in the development of TrKA kinase inhibitors, showcases his dedication to advancing medical science. His contributions continue to have a significant impact on the treatment of various diseases and disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…